Process for the manufacture of peptides containing cystine
申请人:Ciba-Geigy Corporation
公开号:US03994871A1
公开(公告)日:1976-11-30
Process for the manufacture of peptides which contain more than one disulphide bond characterized in that in one or two aminoacid sequences containing cysteine, in which disulphide bonds are to be produced, two cysteine radicals which are to be linked are protected by a mercapto-protective group R.sub.1 of the aralkyl type, two further cysteine radicals are protected by an acylaminomethyl group R.sub.2, the protective groups R.sub.1 are removed by treatment with iodine in the presence of a polyhalogenated lower aliphatic hydroxy compound or oxo compound, or a corresponding lower alkanoic acid lower alkyl ester, at the same time forming the disulphide bond between these cysteine radicals, which are protected by R.sub.1, and at any desired point after removal of the polyhalogenated compound the second disulphide bridge is formed in the usual manner.
Perich, John W.; Alewood, Paul F.; Johns, R. B., Australian Journal of Chemistry, 1987, vol. 40, # 2, p. 257 - 271
作者:Perich, John W.、Alewood, Paul F.、Johns, R. B.
DOI:——
日期:——
PERICH, JOHN W.;ALEWOOD, PAUL F.;JOHNS, R. B., AUSTRAL. J. CHEM., 40,(1987) N 2, 257-271
作者:PERICH, JOHN W.、ALEWOOD, PAUL F.、JOHNS, R. B.
DOI:——
日期:——
Studies on Polypeptides, IV. The Synthesis of C-Peptide of Human Proinsulin
作者:Vinod K. Naithani
DOI:10.1515/bchm2.1973.354.1.659
日期:1973.1
Substrate Peptidomimetic Inhibitors of
<i>P. falciparum</i>
Plasmepsin X with Potent Antimalarial Activity
作者:Lachlan W. Richardson、Trent D. Ashton、Madeline G. Dans、Nghi Nguyen、Paola Favuzza、Tony Triglia、Anthony N. Hodder、Anna Ngo、Kate E. Jarman、Alan F. Cowman、Brad E. Sleebs
DOI:10.1002/cmdc.202200306
日期:2022.9.16
Substrate mimicry: Substratepeptidomimetics were designed and showed potent inhibition of plasmepsinX (PMX). The peptidomimetics block PMX ligand processing, arrest asexual parasites at the schizont stage and potently kill P. falciparum parasites. The peptidomimetics will further assist in the understanding of PMX selectivity and in the development of PMX targeted antimalarials.
底物拟态:设计了底物拟肽并显示出对血浆蛋白酶 X (PMX) 的有效抑制作用。肽模拟物阻断 PMX 配体加工,在裂殖体阶段阻止无性寄生虫并有效杀死恶性疟原虫寄生虫。肽模拟物将进一步帮助理解 PMX 选择性和开发 PMX 靶向抗疟药。